|
| 37917186 | The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study. | Clin Exp Metastasis | 2024 |
| 37917186 | The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study. | Clin Exp Metastasis | 2024 |
| 36705597 | Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases. | Clin Cancer Res | 2023 |
| 37581870 | A perspective on the metastasis suppressor field. | Cancer Metastasis Rev | 2023 |
| 36912773 | Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer. | Mol Cancer Ther | 2023 |
| 36705597 | Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases. | Clin Cancer Res | 2023 |
| 37541280 | National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities. | Lancet Oncol | 2023 |
| 37581870 | A perspective on the metastasis suppressor field. | Cancer Metastasis Rev | 2023 |
| 37541280 | National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities. | Lancet Oncol | 2023 |
| 36912773 | Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer. | Mol Cancer Ther | 2023 |
| 35121997 | Keeping brain metastases dormant. | Nat Cancer | 2022 |
| 35939247 | Metastasis suppressor NME1 in exosomes or liposomes conveys motility and migration inhibition in breast cancer model systems. | Clin Exp Metastasis | 2022 |
| 35121997 | Keeping brain metastases dormant. | Nat Cancer | 2022 |
| 35939247 | Metastasis suppressor NME1 in exosomes or liposomes conveys motility and migration inhibition in breast cancer model systems. | Clin Exp Metastasis | 2022 |
| 33262521 | Endocytosis: a pivotal pathway for regulating metastasis. | Br J Cancer | 2021 |
| 33443114 | Identification and Characterization of Cancer Cells That Initiate Metastases to the Brain and Other Organs. | Mol Cancer Res | 2021 |
| 34253912 | The blood-tumour barrier in cancer biology and therapy. | Nat Rev Clin Oncol | 2021 |
| 34083229 | Aging and CNS Myeloid Cell Depletion Attenuate Breast Cancer Brain Metastasis. | Clin Cancer Res | 2021 |
| 33262521 | Endocytosis: a pivotal pathway for regulating metastasis. | Br J Cancer | 2021 |
| 34674701 | The mitochondrially-localized nucleoside diphosphate kinase D (NME4) is a novel metastasis suppressor. | BMC Biol | 2021 |
| 34674701 | The mitochondrially-localized nucleoside diphosphate kinase D (NME4) is a novel metastasis suppressor. | BMC Biol | 2021 |
| 34083229 | Aging and CNS Myeloid Cell Depletion Attenuate Breast Cancer Brain Metastasis. | Clin Cancer Res | 2021 |
| 34253912 | The blood-tumour barrier in cancer biology and therapy. | Nat Rev Clin Oncol | 2021 |
| 33443114 | Identification and Characterization of Cancer Cells That Initiate Metastases to the Brain and Other Organs. | Mol Cancer Res | 2021 |
| 32270710 | Temozolomide in secondary prevention of HER2-positive breast cancer brain metastases. | Future Oncol | 2020 |
| 32386414 | HER2 antibody-drug conjugate controls growth of breast cancer brain metastases in hematogenous xenograft models, with heterogeneous blood-tumor barrier penetration unlinked to a passive marker. | Neuro Oncol | 2020 |
| 32270710 | Temozolomide in secondary prevention of HER2-positive breast cancer brain metastases. | Future Oncol | 2020 |
| 32647134 | Resistance to the CHK1 inhibitor prexasertib involves functionally distinct CHK1 activities in BRCA wild-type ovarian cancer. | Oncogene | 2020 |
| 32641416 | Brain Metastasis Cell Lines Panel: A Public Resource of Organotropic Cell Lines. | Cancer Res | 2020 |
| 32647134 | Resistance to the CHK1 inhibitor prexasertib involves functionally distinct CHK1 activities in BRCA wild-type ovarian cancer. | Oncogene | 2020 |
| 32641416 | Brain Metastasis Cell Lines Panel: A Public Resource of Organotropic Cell Lines. | Cancer Res | 2020 |
| 32386414 | HER2 antibody-drug conjugate controls growth of breast cancer brain metastases in hematogenous xenograft models, with heterogeneous blood-tumor barrier penetration unlinked to a passive marker. | Neuro Oncol | 2020 |
| 30514977 | A framework for the development of effective anti-metastatic agents. | Nat Rev Clin Oncol | 2019 |
| 31685984 | Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis. | Nat Cell Biol | 2019 |
| 30514977 | A framework for the development of effective anti-metastatic agents. | Nat Rev Clin Oncol | 2019 |
| 30655533 | Brain metastases. | Nat Rev Dis Primers | 2019 |
| 31478503 | Antibody-drug conjugates for cancer. | Lancet | 2019 |
| 30796353 | Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases. | Oncogene | 2019 |
| 30777098 | MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer. | Breast Cancer Res | 2019 |
| 31311812 | Metastasis Suppressors NME1 and NME2 Promote Dynamin 2 Oligomerization and Regulate Tumor Cell Endocytosis, Motility, and Metastasis. | Cancer Res | 2019 |
| 31685984 | Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis. | Nat Cell Biol | 2019 |
| 31311812 | Metastasis Suppressors NME1 and NME2 Promote Dynamin 2 Oligomerization and Regulate Tumor Cell Endocytosis, Motility, and Metastasis. | Cancer Res | 2019 |
| 31478503 | Antibody-drug conjugates for cancer. | Lancet | 2019 |
| 30777098 | MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer. | Breast Cancer Res | 2019 |
| 30796353 | Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases. | Oncogene | 2019 |
| 30655533 | Brain metastases. | Nat Rev Dis Primers | 2019 |
| 29247440 | Analysis of breast cancer in young women in the Department of Defense (DOD) database. | Breast Cancer Res Treat | 2018 |
| 28967874 | Metastasis suppressors: functional pathways. | Lab Invest | 2018 |
| 30006619 | Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases. | Nat Commun | 2018 |
| 29625058 | Retraction Notice to: FMN2 Makes Perinuclear Actin to Protect Nuclei during Confined Migration and Promote Metastasis. | Cell | 2018 |